GAMT

Chr 19AR

guanidinoacetate N-methyltransferase

Also known as: CCDS2, HEL-S-20, PIG2, TP53I2

The protein encoded by this gene is a methyltransferase that converts guanidoacetate to creatine, using S-adenosylmethionine as the methyl donor. Defects in this gene have been implicated in neurologic syndromes and muscular hypotonia, probably due to creatine deficiency and accumulation of guanidinoacetate in the brain of affected individuals. Two transcript variants encoding different isoforms have been described for this gene. Pseudogenes of this gene are found on chromosomes 2 and 13. [provided by RefSeq, Feb 2012]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 1.261 OMIM phenotype
VCEP Guidelines: Cerebral Creatine DeficiencyReleased
View SpecificationsClinGen Panel
Clinical SummaryGAMT
🧬
Gene-Disease Validity (ClinGen)
guanidinoacetate methyltransferase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
127 unique Pathogenic / Likely Pathogenic· 221 VUS of 613 total submissions
📖
GeneReview available — GAMT
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.26LOEUF
pLI 0.009
Z-score 1.11
OE 0.55 (0.271.26)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.09Z-score
OE missense 1.02 (0.891.17)
153 obs / 150.0 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.55 (0.271.26)
00.351.4
Missense OE?1.02 (0.891.17)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 4 / 7.2Missense obs/exp: 153 / 150.0Syn Z: 0.02
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGAMT-related guanidinoacetate methyltransferase deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7131th %ile
GOF
0.5563th %ile
LOF
0.2091th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

613 submitted variants in ClinVar

Classification Summary

Pathogenic55
Likely Pathogenic72
VUS221
Likely Benign241
Benign17
Conflicting2
55
Pathogenic
72
Likely Pathogenic
221
VUS
241
Likely Benign
17
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
35
16
3
1
55
Likely Pathogenic
44
25
3
0
72
VUS
3
187
20
11
221
Likely Benign
1
15
85
140
241
Benign
0
5
9
3
17
Conflicting
2
Total83248120155608

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

24 pathogenic / likely-pathogenic (of 36) ClinVar copy-number / structural variants overlap GAMT — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GAMT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →